- A study on changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma
-
Park CJ, Cho HI, Kim SI
- KMID: 1421508
- J Korean Med Sci.
- 1991 Mar;6(1):1-6.
- doi: 10.3346/jkms.1991.6.1.1
The authors conducted an investigation focusing mainly on the activities of the inhibitory factors of the coagulation and fibrinolysis processes in 35 normal adults and 72 liver cirrhosis and/or hepatoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity
-
Lee ES, Kim SH, Kim HJ, Kim KH, Lee BS, Ku BJ
- KMID: 2412195
- Gut Liver.
- 2017 Mar;11(2):276-282.
- doi: 10.5009/gnl16049
BACKGROUND/AIMS: Growth differentiation factor 15 (GDF-15) belongs to the transforming growth factor-β superfamily. GDF-15 is emerging as a biomarker for several diseases. The aim of this study was to determine... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Serum CA 125 in Patients with Chronic Liver Diseases
-
Kim YS, Kim DY, Ryu KH, Song JH, Kim MS, Jung HS, Park JY, Jung HK, Yoo K, Moon IH, Baek JY
- KMID: 1112192
- Korean J Gastroenterol.
- 2003 Nov;42(5):409-414.
BACKGROUND/AIMS: The clinical significance of serum CA 125 levels in patients with chronic liver disease has not been widely appreciated in relation to the severity of the disease. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
-
Lim YL, Choi E, Jang YO, Cho YZ, Kang YS, Baik SK, Kwon SO, Kim MY
- KMID: 2382351
- Gut Liver.
- 2016 Jan;10(1):109-116.
- doi: 10.5009/gnl14345
BACKGROUND/AIMS: Levels of serum apelin (s-apelin), an endogenous ligand for angiotensin-like receptor 1, have been shown to be related to hepatic fibrosis and hemodynamic abnormalities in preclinical studies. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis
-
Wu C, Liu L, Zhao P, Tang D, Yao D, Zhu L, Wang Z
- KMID: 2234074
- Gut Liver.
- 2015 Sep;9(5):665-671.
- doi: 10.5009/gnl14212
BACKGROUND/AIMS: To screen for serum protein/peptide biomarkers of hepatitis B virus (HBV)-associated chronic hepatic lesions in an attempt to profile the progression of HBV-associated chronic hepatic lesions using surface-enhanced laser... -
- CITED
-
- Close
- SHARE
-
- Close
- N-terminal Pro B-type Natriuretic Peptide and the Evaluation of Cardiac Dysfunction and Severity of Disease in Cirrhotic Patients
-
Woo JJ, Koh YY, Kim HJ, Chung JW, Chang KS, Hong SP
- KMID: 1793199
- Yonsei Med J.
- 2008 Aug;49(4):625-631.
- doi: 10.3349/ymj.2008.49.4.625
PURPOSE: Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting... -
- CITED
-
- Close
- SHARE
-
- Close
- U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
-
Benz F, Roderburg , Vargas Cardenas D, Vucur M, Gautheron , Koch A, Zimmermann H, Janssen J, Nieuwenhuijsen L, Luedde M, Frey N, Tacke F, Trautwein , Luedde T
- KMID: 2154261
- Exp Mol Med.
- 2013 Sep;45(9):e42.
MicroRNA (miRNA) levels in serum have recently emerged as potential novel biomarkers for various diseases. miRNAs are routinely measured by standard quantitative real-time PCR (qPCR); however, the high sensitivity of... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Helicobacter pylori with Elevated Blood Ammonia Levels in Cirrhotic Patients: A Meta-Analysis
-
Jiang HX, Qin SY, Min ZG, Xie MZ, Lin T, Hu BL, Guo XY
- KMID: 2158215
- Yonsei Med J.
- 2013 Jul;54(4):832-838.
- doi: 10.3349/ymj.2013.54.4.832
PURPOSE: The association between Helicobacter pylori (H. pylori) and blood ammonia levels in cirrhotic patients is controversial. We aimed to clarify this controvercy by performing a meta-analysis of published studies. MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
